All Posts

Most clinics don’t realize how much patient drop-off is quietly costing them every single month. Not because they aren’t good at what they do.Not because their offer is weak. But because patient churn doesn’t feel dramatic when it’s happening. It looks like a few missed check-ins.A patient who “takes a break.” Someone who says they’ll restart next month and never does. Individually, it feels small. But when you zoom out, it compounds fast. The Hidden Revenue Leak Most Clinics

GLP-1 Care Is Advancing, But the Model Is Incomplete GLP-1 programs have rapidly evolved over the past several years. Clinics have improved onboarding, refined dosing protocols, and expanded access through telehealth and hybrid care models. Patient demand continues to grow, and outcomes have become more widely recognized. From a clinical standpoint, the foundation is strong. However, as programs scale, a different challenge begins to surface. Retention becomes less predictabl

Churn Is the Silent Revenue Leak Most Clinics Underestimate In telehealth weight loss programs, growth is often the primary focus. Clinics invest in acquisition, optimize funnels, and work to increase patient volume. On the surface, this creates momentum. beneath that growth, a quieter pattern is often forming. Patients who start strong begin to disengage over time. Some reduce adherence. Others stop responding. Many leave without formally canceling or clearly communicating w

The Gap Most Clinics Don’t See Clearly Semaglutide programs are typically structured around key clinical interactions. Patients are onboarded, educated, and given clear guidance during appointments. Follow-ups are scheduled, progress is reviewed, and adjustments are made as needed. On paper, this structure appears complete. The patient receives care, the provider delivers oversight, and the program progresses as designed. But the majority of the patient experience does not ha

The 60-Day Pattern Clinics Consistently See Most clinics don’t need a report to recognize it. The first few weeks of a GLP-1 program tend to be strong. Patients are engaged, responsive, and closely following the structure that has been put in place. Early progress reinforces that behavior, and momentum builds quickly. Then, somewhere between day 45 and day 60, that momentum begins to shift. Engagement becomes less consistent, communication slows, and adherence starts to vary.

The Problem Isn’t Awareness. It’s What Happens After Most clinics don’t have a demand problem right now. GLP-1 programs are filling, patients are enrolling, and the first few weeks typically look strong. People are motivated, engaged, and following the plan closely. Then something shifts. Not all at once, and not dramatically. But consistently enough that it shows up across almost every program. By the second month, engagement starts to soften. Patients become less consistent

GLP-1 medications have become an important tool in managing chronic conditions such as type 2 diabetes and obesity. These therapies require ongoing patient engagement and adherence to achieve optimal outcomes. For telehealth companies, medical clinics, and healthcare operators prescribing GLP-1 medications, supporting patients between visits is a critical challenge. Expert GLP-1 patient support services offer a practical solution to improve patient retention, adherence, and o

GLP-1 medications have become a significant part of managing certain chronic conditions, particularly for women navigating weight management and metabolic health. For telehealth companies, medical clinics, and healthcare operators prescribing these therapies, establishing effective pricing strategies for GLP-1 support is essential. This support goes beyond the medication itself, encompassing behavioral guidance, adherence encouragement, and patient retention efforts between c

GLP-1 receptor agonists have become an important option in managing conditions such as type 2 diabetes and obesity. However, patient drop-off rates remain a significant challenge for healthcare providers prescribing these medications. Understanding the factors that contribute to discontinuation and implementing effective strategies to support patients can improve adherence and outcomes. This article explores practical approaches to reduce GLP-1 patient drop-off rates, focusin

GLP-1 medications have become an important option for managing chronic conditions such as type 2 diabetes and obesity. However, the success of these therapies depends heavily on patient adherence and ongoing support. For telehealth companies, medical clinics, and healthcare operators prescribing GLP-1 medications, implementing effective support programs is essential to improve patient retention, adherence, and overall experience between visits. This article explores practical

GLP-1 medications have become an important tool in managing conditions such as type 2 diabetes and obesity. However, the success of these therapies depends not only on prescribing the medication but also on supporting patients throughout their treatment journey. Reliable patient support services can help improve adherence, retention, and overall patient experience between clinical visits. This article explores how healthcare providers can find and implement effective GLP-1 pa

GLP-1 medications have become an important tool in managing weight and metabolic health. For healthcare providers prescribing these therapies, ensuring patients stay engaged and adherent between visits is critical. One key factor influencing patient retention and satisfaction is the affordability and consistency of support services related to GLP-1 treatments. This article explores practical approaches to pricing GLP-1 support programs that balance cost-effectiveness with qua

Starting or continuing a GLP-1 medication journey can feel like stepping into unfamiliar territory. The information available is often scattered, and the emotional and practical support needed is not always easy to find. I want to share some grounded insights and resources that have helped me and others navigate this path with more clarity and steadiness. This guide is meant to be a calm companion, offering practical advice and pointing to community resources that respect you

What is GLP-1? GLP-1, or glucagon-like peptide-1, is a hormone produced in the intestines. It plays a crucial role in glucose metabolism by stimulating insulin secretion and inhibiting glucagon release. This hormone also slows gastric emptying, which helps regulate appetite and food intake. How Do GLP-1 Treatments Work? GLP-1 treatments are synthetic versions of the natural hormone. They mimic the effects of GLP-1 in the body, leading to several beneficial outcomes: Increased

Managing weight and health can be a challenging journey, especially for those dealing with obesity or related conditions. One of the most promising advancements in recent years has been the development of GLP-1 receptor agonists. These medications have shown significant potential in aiding weight loss and improving metabolic health. If you are considering or currently using GLP-1 medications, this guide will provide you with essential tips and support to navigate your journey

GLP-1 medications have gained significant attention in recent years, particularly for their role in managing weight and type 2 diabetes. For women, understanding these medications can be crucial, especially as they navigate health challenges unique to their gender. This guide aims to provide a comprehensive overview of GLP-1 medications, their benefits, potential side effects, and considerations for women. What are GLP-1 Medications? GLP-1 stands for glucagon-like peptide-1,